Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Safety and Risk of Allogeneic Peripheral Blood Stem Cell Donation: The Comprehensive Report of Nation-Wide Consecutively Pre-Registered 3,264 Family Donor Survey In 10years Project by Japan Society for Hematopoietic Cell Transplantation.

Blood (2010) 116 (21): 1180.

https://doi.org/10.1182/blood.V116.21.1180.1180

Published: 2010

Journal Articles

The Safety and the Risk of Allogeneic Bone Marrow and Peripheral Blood Stem Cell Donation; Results of Nation-Wide Consecutive Pre-Transplant Registration of Related Donors in Japan.

Shunichi Kato, MD, PhD, Yoshihisa Kodera, MD, PhD, Kazuhito Yamamoto, MD, PhD, Mine Harada, MD, PhD, Nobuyuki Hamajima, MD, PhD, Shigetaka Asano, MD, PhD, Yasuo Ikeda, MD, PhD, Masahiro Imamura, MD, PhD, Yasuo Morishima, MD, PhD, Keisei Kawa, MD, PhD, Tatsutoshi Nakahata, MD, PhD, Mitsune Tanimoto, MD, PhD, Shintaro Shiobara, MD, PhD, Hiroo Dohy, MD, PhD, Sun-Won Kim, MD, PhD, Yoshinobu Kanda, MD, PhD

Blood (2007) 110 (11): 3275.

https://doi.org/10.1182/blood.V110.11.3275.3275

Published: 2007

Journal Articles

Severe Adverse Events of Allogeneic Related Peripheral Blood Stem Cell Donors -Results of Nation-Wide 3,262 Consecutively and Prospectively Registered Case-Survey in Japan and of Its Comparison to the Outcome of Retrospective Survey Shared with EBMT for Stem Cell Donors.

Yoshihisa Kodera, MD, Shunichi Kato, MD, Mine Harada, MD, Shintaro Shiobara, MD, Nobuyuki Hamajima, MD, Yasuo Morishima, MD, Mitsune Tanimoto, MD, Shigetaka Asano, MD, Yasuo Ikeda, MD, Hiroo Dohi, MD, Tatsutoshi Nakahata, MD, Masahiro Imamura, MD, Keisei Kawa, MD, Yoichi Takaue, MD, Yoshinobu Kanda, MD, Kazuhito Yamamoto, MD, Genevieve Favre, MD, Alois Gratwohl, MD

Blood (2005) 106 (11): 1119.

https://doi.org/10.1182/blood.V106.11.1119.1119

Published: 2005

Journal Articles

Chronic Graft-Versus-Host Disease after Allogenaic Bone Marrow Transplantation in Japan: Identification of Risk Factors and Prognostication.

Yoshiko Atsuta, MD, Ritsuro Suzuki, MD, Kazuhito Yamamoto, MD, Seitaro Terakura, MD, Hiroatsu Iida, MD, Akio Kohno, MD, Tomoki Naoe, MD, Hiroshi Sao, MD, Yoshihisa Kodera, MD, Yasuo Morishima, MD, Nobuyuki Hamajima, MD, Yoshihisa Morishita, MD

Blood (2005) 106 (11): 1808.

https://doi.org/10.1182/blood.V106.11.1808.1808

Published: 2005

Journal Articles

Role of Chemotherapy before Allogeneic Stem Cell Transplantation (ALLO-SCT) from an HLA-Identical Sibling Donor for Myelodysplastic Syndrome (MDS).

Kunihisa Nakai, Yoshinobu Kanda, Shirou Fukuhara, Hisashi Sakamaki, Shinichiro Okamoto, Yoshihisa Kodera, Ryuji Tanosaki, Satoshi Takahashi, Takafumi Matsushima, Yoshiko Atsuta, Nobuyuki Hamajima, Masaharu Kasai, Shunichi Kato

Blood (2004) 104 (11): 5126.

https://doi.org/10.1182/blood.V104.11.5126.5126

Published: 2004

Journal Articles

Allogeneic hematopoietic stem cell transplantation from family members other than HLA-identical siblings over the last decade (1991-2000)

Yoshinobu Kanda, Shigeru Chiba, Hisamaru Hirai, Hisashi Sakamaki, Tohru Iseki, Yoshihisa Kodera, Takahiro Karasuno, Shinichiro Okamoto, Noriyuki Hirabayashi, Koji Iwato, Atsuo Maruta, Yoshihiro Fujimori, Tatsuo Furukawa, Shin Mineishi, Keitaro Matsuo, Nobuyuki Hamajima, Masahiro Imamura

Blood (2003) 102 (4): 1541–1547.

https://doi.org/10.1182/blood-2003-02-0430

Published: 2003

Journal Articles

The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors

Yasuo Morishima, Takehiko Sasazuki, Hidetoshi Inoko, Takeo Juji, Tatsuya Akaza, Ken Yamamoto, Yoshihide Ishikawa, Shunichi Kato, Hiroshi Sao, Hisashi Sakamaki, Keisei Kawa, Nobuyuki Hamajima, Shigetaka Asano, Yoshihisa Kodera

Blood (2002) 99 (11): 4200–4206.

https://doi.org/10.1182/blood.V99.11.4200

Published: 2002

Journal Articles

Attribution of posttransplantation toxicity to methotrexate regarding genotype of methylenetetrahydrofolate reductase gene ( MTHFR ) polymorphism needs further clarification

Keitaro Matsuo, Ritsuro Suzuki, Yasuo Morishima, Nobuyuki Hamajima

Blood (2001) 98 (7): 2283.

https://doi.org/10.1182/blood.V98.7.2283

Published: 2001

Journal Articles

Association between polymorphisms of folate- and methionine-metabolizing enzymes and susceptibility to malignant lymphoma

Keitaro Matsuo, Ritsuro Suzuki, Nobuyuki Hamajima, Michinori Ogura, Yoshitoyo Kagami, Hirofumi Taji, Eisei Kondoh, Satoko Maeda, Shoji Asakura, Sadayuki Kaba, Shigeo Nakamura, Masao Seto, Yasuo Morishima, Kazuo Tajima

Blood (2001) 97 (10): 3205–3209.

https://doi.org/10.1182/blood.V97.10.3205

Published: 2001

Journal Articles

Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T/null cell phenotype

Ritsuro Suzuki, Yoshitoyo Kagami, Kengo Takeuchi, Masahiro Kami, Masataka Okamoto, Ryo Ichinohasama, Naoyoshi Mori, Masaru Kojima, Tadashi Yoshino, Hirohiko Yamabe, Mami Shiota, Shigeo Mori, Michinori Ogura, Nobuyuki Hamajima, Masao Seto, Taizan Suchi, Yasuo Morishima, Shigeo Nakamura

Blood (2000) 96 (9): 2993–3000.

https://doi.org/10.1182/blood.V96.9.2993

Published: 2000

Journal Articles

Myelodysplastic Syndrome and Acute Myelogenous Leukemia as a Late Clonal Complication in Children With Acquired Aplastic Anemia

Akira Ohara, Seiji Kojima, Nobuyuki Hamajima, Masahiro Tsuchida, Shinsaku Imashuku, Shigeru Ohta, Hideki Sasaki, Jun Okamura, Kanji Sugita, Hisato Kigasawa, Yukio Kiriyama, Junichi Akatsuka, Ichiro Tsukimoto

Blood (1997) 90 (3): 1009–1013.

https://doi.org/10.1182/blood.V90.3.1009

Published: 1997

NARROW

Safety and Risk of Allogeneic Peripheral Blood Stem Cell Donation: The Comprehensive Report of Nation-Wide Consecutively Pre-Registered 3,264 Family Donor Survey In 10years Project by Japan Society for Hematopoietic Cell Transplantation.

The Safety and the Risk of Allogeneic Bone Marrow and Peripheral Blood Stem Cell Donation; Results of Nation-Wide Consecutive Pre-Transplant Registration of Related Donors in Japan.

Severe Adverse Events of Allogeneic Related Peripheral Blood Stem Cell Donors -Results of Nation-Wide 3,262 Consecutively and Prospectively Registered Case-Survey in Japan and of Its Comparison to the Outcome of Retrospective Survey Shared with EBMT for Stem Cell Donors.

Chronic Graft-Versus-Host Disease after Allogenaic Bone Marrow Transplantation in Japan: Identification of Risk Factors and Prognostication.

Role of Chemotherapy before Allogeneic Stem Cell Transplantation (ALLO-SCT) from an HLA-Identical Sibling Donor for Myelodysplastic Syndrome (MDS).

Allogeneic hematopoietic stem cell transplantation from family members other than HLA-identical siblings over the last decade (1991-2000)

The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors

Attribution of posttransplantation toxicity to methotrexate regarding genotype of methylenetetrahydrofolate reductase gene ( MTHFR ) polymorphism needs further clarification

Association between polymorphisms of folate- and methionine-metabolizing enzymes and susceptibility to malignant lymphoma

Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T/null cell phenotype

Myelodysplastic Syndrome and Acute Myelogenous Leukemia as a Late Clonal Complication in Children With Acquired Aplastic Anemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only